Klf8 was inactivated in antidepressant and insomnia treatments (sertraline, fluoxetine, suvorexant, imipramine, and 8beta) and strongly activated in neurotoxic conditions (Domo, Pb, and rb1 mutants). Here, KLF8 is linked to insomnia measurement.